Article

Waking the dead

Author(s):

I'm a big fan of filmmaker Ken Burns, so I was eager to see a new profile of him in The Atlantic. His films on The Civil War, Baseball and Jazz have not only provided a window into America's history for generations of viewers but also introduced the "Ken Burns effect" to documentary filmmaking. When asked about his insights into storytelling, he revealed a deeply personal motivation: his childhood experience of his mother's cancer."I don't know why I tell stories about history. I mean there are kind of classic, dime-store Ken Burns 'wolf at the door' things. My mother had cancer all of my life. She died when I was 11 and there wasn't a moment from when I was aware, 2 and a half, 3, that there was something dreadfully wrong in my life. It might be that what I'm engaged in in a historical pursuit is a thinly or perhaps thickly disguised waking of the dead. That I try to make Abraham Lincoln and Jackie Robinson and Louis Armstrong come alive and it may be very obvious and very close to home who I'm actually trying to wake up."He goes deeper still. "We have to keep the wolf from the door. We tell stories to continue ourselves. We all think an exception is going to be made in our case and we're going to live forever. Being a human is actually arriving tat the understanding that that's not going to be. Story is there to just remind us that it's just OK."Burns' reflections dovetail with insights from Tani Bahti, a hospice nurse we interviewed for a story on caring for a loved one who has decided to end treatment. Look for it in our summer issue.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Waldenstrom macroglobulinemia is often slow growing, with high survival but lower quality of life over time, explained researcher Alisha Kimble.
Image of woman.
Image of two doctors and text.
Combining JNJ-1900 with Keytruda may improve distant control of lung cancer, explained by Dr. Jared Weiss.
image of serzan.
Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal stromal tumors.
Image of two doctors with text.
Image of doctors with text.
Imiage of two doctors with text.
Treatment with zanzalintinib plus Opdivo and Opdualag is an option worth exploring in patients with previously untreated clear cell renal cell carcinoma
Related Content